Waystar reports Q4 adjusted EPS 36c, consensus 40c

Reports Q4 revenue $304M, consensus $294.79M. “Waystar (WAY) is delivering strong growth and momentum-driving record bookings, integrating the Iodine acquisition ahead of plan, and accelerating AI-powered innovation across our platform,” said Matt Hawkins, Chief Executive Officer of Waystar. “We are leading healthcare’s AI transformation by advancing the autonomous revenue cycle, leveraging unmatched proprietary data and deep domain expertise to deliver meaningful outcomes for providers. Our 2026 guidance reflects a robust pipeline, accelerating demand for an end-to-end AI-powered platform, and disciplined execution to sustain durable, profitable growth.”